http://rdf.disgenet.org/resource/nanopub/NP322633.RAh_9X-DIX38zNOQNmI0zcCOjczTCxYcP_-ojQaQmrwAU#head
http://rdf.disgenet.org/resource/nanopub/NP322633.RAh_9X-DIX38zNOQNmI0zcCOjczTCxYcP_-ojQaQmrwAU
http://www.nanopub.org/nschema#hasAssertion
http://rdf.disgenet.org/resource/nanopub/NP322633.RAh_9X-DIX38zNOQNmI0zcCOjczTCxYcP_-ojQaQmrwAU#assertion
http://rdf.disgenet.org/resource/nanopub/NP322633.RAh_9X-DIX38zNOQNmI0zcCOjczTCxYcP_-ojQaQmrwAU
http://www.nanopub.org/nschema#hasProvenance
http://rdf.disgenet.org/resource/nanopub/NP322633.RAh_9X-DIX38zNOQNmI0zcCOjczTCxYcP_-ojQaQmrwAU#provenance
http://rdf.disgenet.org/resource/nanopub/NP322633.RAh_9X-DIX38zNOQNmI0zcCOjczTCxYcP_-ojQaQmrwAU
http://www.nanopub.org/nschema#hasPublicationInfo
http://rdf.disgenet.org/resource/nanopub/NP322633.RAh_9X-DIX38zNOQNmI0zcCOjczTCxYcP_-ojQaQmrwAU#publicationInfo
http://rdf.disgenet.org/resource/nanopub/NP322633.RAh_9X-DIX38zNOQNmI0zcCOjczTCxYcP_-ojQaQmrwAU
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.nanopub.org/nschema#Nanopublication
http://rdf.disgenet.org/resource/nanopub/NP322633.RAh_9X-DIX38zNOQNmI0zcCOjczTCxYcP_-ojQaQmrwAU#assertion
http://rdf.disgenet.org/resource/gda/DGNa2842605266c12cc1edf6503fa9f3ac4
http://semanticscience.org/resource/SIO_000628
http://identifiers.org/ncbigene/1956
http://rdf.disgenet.org/resource/gda/DGNa2842605266c12cc1edf6503fa9f3ac4
http://semanticscience.org/resource/SIO_000628
http://linkedlifedata.com/resource/umls/id/C0001418
http://rdf.disgenet.org/resource/gda/DGNa2842605266c12cc1edf6503fa9f3ac4
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://semanticscience.org/resource/SIO_001122
http://rdf.disgenet.org/resource/nanopub/NP322633.RAh_9X-DIX38zNOQNmI0zcCOjczTCxYcP_-ojQaQmrwAU#provenance
http://rdf.disgenet.org/resource/nanopub/NP322633.RAh_9X-DIX38zNOQNmI0zcCOjczTCxYcP_-ojQaQmrwAU#assertion
http://purl.org/dc/terms/description
[The major recommendations are to use testing for EGFR mutations and ALK fusions to guide patient selection for therapy with an epidermal growth factor receptor (EGFR) or anaplastic lymphoma kinase (ALK) inhibitor, respectively, in all patients with advanced-stage adenocarcinoma, regardless of sex, race, smoking history, or other clinical risk factors, and to prioritize EGFR and ALK testing over other molecular predictive tests.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine.
http://rdf.disgenet.org/resource/nanopub/NP322633.RAh_9X-DIX38zNOQNmI0zcCOjczTCxYcP_-ojQaQmrwAU#assertion
http://purl.org/ontology/wi/core#evidence
http://rdf.disgenet.org/v5.0.0/void/source_evidence_literature
http://rdf.disgenet.org/resource/nanopub/NP322633.RAh_9X-DIX38zNOQNmI0zcCOjczTCxYcP_-ojQaQmrwAU#assertion
http://semanticscience.org/resource/SIO_000772
http://identifiers.org/pubmed/23551194
http://rdf.disgenet.org/resource/nanopub/NP322633.RAh_9X-DIX38zNOQNmI0zcCOjczTCxYcP_-ojQaQmrwAU#assertion
http://www.w3.org/ns/prov#wasDerivedFrom
http://rdf.disgenet.org/v5.0.0/void/BEFREE
http://rdf.disgenet.org/resource/nanopub/NP322633.RAh_9X-DIX38zNOQNmI0zcCOjczTCxYcP_-ojQaQmrwAU#assertion
http://www.w3.org/ns/prov#wasGeneratedBy
http://purl.obolibrary.org/obo/ECO_0000203
http://rdf.disgenet.org/v5.0.0/void/BEFREE
http://purl.org/pav/importedOn
2017-02-19
http://rdf.disgenet.org/v5.0.0/void/source_evidence_literature
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.obolibrary.org/obo/ECO_0000212
http://rdf.disgenet.org/v5.0.0/void/source_evidence_literature
http://www.w3.org/2000/01/rdf-schema#comment
Gene-disease associations inferred from text-mining the literature.
http://rdf.disgenet.org/v5.0.0/void/source_evidence_literature
http://www.w3.org/2000/01/rdf-schema#label
DisGeNET evidence - LITERATURE
http://rdf.disgenet.org/resource/nanopub/NP322633.RAh_9X-DIX38zNOQNmI0zcCOjczTCxYcP_-ojQaQmrwAU#publicationInfo
http://rdf.disgenet.org/resource/nanopub/NP322633.RAh_9X-DIX38zNOQNmI0zcCOjczTCxYcP_-ojQaQmrwAU
http://purl.org/dc/terms/created
2017-10-17T13:12:14+02:00
http://rdf.disgenet.org/resource/nanopub/NP322633.RAh_9X-DIX38zNOQNmI0zcCOjczTCxYcP_-ojQaQmrwAU
http://purl.org/dc/terms/rights
http://opendatacommons.org/licenses/odbl/1.0/
http://rdf.disgenet.org/resource/nanopub/NP322633.RAh_9X-DIX38zNOQNmI0zcCOjczTCxYcP_-ojQaQmrwAU
http://purl.org/dc/terms/rightsHolder
http://rdf.disgenet.org/v5.0.0/void/IBIGroup
http://rdf.disgenet.org/resource/nanopub/NP322633.RAh_9X-DIX38zNOQNmI0zcCOjczTCxYcP_-ojQaQmrwAU
http://purl.org/dc/terms/subject
http://semanticscience.org/resource/SIO_000983
http://rdf.disgenet.org/resource/nanopub/NP322633.RAh_9X-DIX38zNOQNmI0zcCOjczTCxYcP_-ojQaQmrwAU
http://purl.org/net/provenance/ns#usedData
http://rdf.disgenet.org/v5.0.0/void/disgenetv3.0rdf
http://rdf.disgenet.org/resource/nanopub/NP322633.RAh_9X-DIX38zNOQNmI0zcCOjczTCxYcP_-ojQaQmrwAU
http://purl.org/pav/authoredBy
http://orcid.org/0000-0001-5999-6269
http://rdf.disgenet.org/resource/nanopub/NP322633.RAh_9X-DIX38zNOQNmI0zcCOjczTCxYcP_-ojQaQmrwAU
http://purl.org/pav/authoredBy
http://orcid.org/0000-0002-7534-7661
http://rdf.disgenet.org/resource/nanopub/NP322633.RAh_9X-DIX38zNOQNmI0zcCOjczTCxYcP_-ojQaQmrwAU
http://purl.org/pav/authoredBy
http://orcid.org/0000-0002-9383-528X
http://rdf.disgenet.org/resource/nanopub/NP322633.RAh_9X-DIX38zNOQNmI0zcCOjczTCxYcP_-ojQaQmrwAU
http://purl.org/pav/authoredBy
http://orcid.org/0000-0003-0169-8159
http://rdf.disgenet.org/resource/nanopub/NP322633.RAh_9X-DIX38zNOQNmI0zcCOjczTCxYcP_-ojQaQmrwAU
http://purl.org/pav/authoredBy
http://orcid.org/0000-0003-1244-7654
http://rdf.disgenet.org/resource/nanopub/NP322633.RAh_9X-DIX38zNOQNmI0zcCOjczTCxYcP_-ojQaQmrwAU
http://purl.org/pav/createdBy
http://orcid.org/0000-0003-0169-8159
http://rdf.disgenet.org/resource/nanopub/NP322633.RAh_9X-DIX38zNOQNmI0zcCOjczTCxYcP_-ojQaQmrwAU
http://purl.org/pav/version
v5.0.0.0
http://rdf.disgenet.org/v5.0.0/void/disgenetv3.0rdf
http://purl.org/pav/version
v5.0.0